Skip to main content
Clinical Trials/NCT00952458
NCT00952458
Completed
Not Applicable

Bispectral Index Monitoring as an Adjunct to Standard Monitoring of Sedation During Endoscopic Retrograde Cholangiopancreaticography

Technical University of Munich1 site in 1 country144 target enrollmentJuly 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gastrointestinal Endoscopy
Sponsor
Technical University of Munich
Enrollment
144
Locations
1
Primary Endpoint
Cardiopulmonary complications of sedation
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

This randomized study investigates the benefits of an additional Bispectral Index monitoring of depth of sedation during endoscopic retrograde cholangiopancreaticography. A bispectral index (BIS) monitor is a neurophysiological monitoring device which continually analyses a patient's electroencephalograms during general anaesthesia to assess the level of consciousness during anaesthesia.

Registry
clinicaltrials.gov
Start Date
July 2009
End Date
May 2010
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Technical University of Munich

Eligibility Criteria

Inclusion Criteria

  • Indication for ERCP (Endoscopic Retrograde Cholangiopancreatography) with midazolam and propofol sedation

Exclusion Criteria

  • Missing informed consent
  • Preexisting neurological deficit
  • Known pregnancy
  • Hypotension (RRsys\<90mmHg), bradycardia (HR\<50/min), hypoxia (SaO2\<90%)

Outcomes

Primary Outcomes

Cardiopulmonary complications of sedation

Time Frame: 1-4 hours

Secondary Outcomes

  • Efficacy of sedation(1-4 hours)

Study Sites (1)

Loading locations...

Similar Trials